Explore more publications!
Health Monitor Liechtenstein
Got News to Share?

Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 31, 2025

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead
October 31, 2025

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

Indeterminate GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
October 31, 2025

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Alps Announces Closing of Business Combination with Globalink Investment Inc.
October 31, 2025

Alps Announces Closing of Business Combination with Globalink Investment Inc.

Indeterminate GlobeNewswire
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
October 31, 2025

Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
October 31, 2025

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Indeterminate GlobeNewswire
Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025
October 31, 2025

Vireo Growth Inc. to Release Third Quarter 2025 Results on November 12, 2025

Indeterminate GlobeNewswire
Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report
October 31, 2025

Alterity Therapeutics: Appendix 4C – Q1 FY26 Quarterly Cash Flow Report

Indeterminate GlobeNewswire
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
October 31, 2025

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025
October 31, 2025

Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025

Indeterminate GlobeNewswire
Upstream Bio to Participate in Upcoming November Investor Conferences
October 31, 2025

Upstream Bio to Participate in Upcoming November Investor Conferences

Indeterminate GlobeNewswire
Immuron Announces Clinical Trial Update
October 31, 2025

Immuron Announces Clinical Trial Update

Indeterminate GlobeNewswire
Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong
October 31, 2025

Unprecedented Clinical data from the Landmark BOOSTB4 Trial to be presented at the 15th International Conference on Osteogenesis Imperfecta in Hong Kong

Indeterminate GlobeNewswire
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
October 31, 2025

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025

Indeterminate GlobeNewswire
NANOBIOTIX annonce un accord stratégique avec HealthCare Royalty pour un montant maximum de 71 millions de dollars et prolonge ainsi son horizon de trésorerie pour une croissance durable
October 31, 2025

NANOBIOTIX annonce un accord stratégique avec HealthCare Royalty pour un montant maximum de 71 millions de dollars et prolonge ainsi son horizon de trésorerie pour une croissance durable

Indeterminate GlobeNewswire
NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
October 31, 2025

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

Indeterminate GlobeNewswire
Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg
October 31, 2025

Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions